Rosenwald Lindsay A MD's Form 4 filing
Fortress Biotech, Inc. (FBIO) · filed Sep 25, 2024
- Accession no.
- 0001415889-24-023957
- Filed
- Sep 25, 2024, 4:45 PM ET
- Trade date
- Sep 23, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $1.40M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rosenwald Lindsay A MDCIK 0000941841 | Director, Officer (PRESIDENT, CEO & CHAIRMAN), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2024 | Common stock, par value $0.001 | PPurchaseAcquired | +763,359 | $1.84 | +$1,404,580.56 | 3,657,264 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2024 | Common Stock | PPurchaseAcquired | +763,359 | $0.125 | +$95,419.88 | 763,359 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.